Profound Medical Corp Stock (PROF) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 295.89%9.83 | 2.48 | 5.34 | 5.98 | 5.29 |
| Cost Of Revenue | 301.12%2.15 | 0.54 | 1.51 | 1.99 | 1.36 |
| Gross Profit | 294.45%7.68 | 1.95 | 3.83 | 3.99 | 3.93 |
19.12%15.50 | 13.01 | 11.85 | 11.36 | 12.84 | |
| Selling, General, and Administrative | 31.74%9.70 | 7.36 | 6.59 | 7.09 | 7.43 |
| Research and Development | 2.69%5.81 | 5.65 | 5.26 | 4.27 | 5.42 |
| Operating Income/Loss | 29.32%-7.82 | -11.07 | -8.02 | -7.37 | -8.91 |
| Nonoperating Income/Loss | 93.99%0.10 | 1.58 | 0.99 | -0.78 | 1.06 |
| Income/Loss From Continuing Operations Before Tax | 18.55%-7.73 | -9.49 | -7.03 | -8.15 | -7.86 |
| Income Tax Expense/Benefit, Current | 88.24%0.01 | 0.07 | 0.03 | 0.01 | 0.10 |
| Income Tax Expense/Benefit, Deferred | 7.69%-0.01 | -0.01 | -0.00 | 0.01 | 0.02 |
| Income Tax Expense/Benefit | 107.27%-0.00 | 0.06 | 0.03 | 0.03 | 0.12 |
19.06%-7.72 | -9.54 | -7.05 | -8.18 | -7.98 | |
| Attributable To Parent | 19.06%-7.72 | -9.54 | -7.05 | -8.18 | -7.98 |
| Available To Common Stockholders, Basic | 19.06%-7.72 | -9.54 | 7.05 | 76.97 | -7.98 |
| Basic Average Shares | 0.57%36.56 | 36.35 | 36.30 | 0.11 | 30.10 |
| Diluted Average Shares | 0.57%36.56 | 36.35 | 36.30 | 0.11 | 30.10 |
| Basic Earnings Per Share | 19.23%-0.21 | -0.26 | 0.19 | 0.27 | 0.26 |
| Diluted Earnings Per Share | 19.23%-0.21 | -0.26 | 0.19 | 0.27 | 0.26 |